Published in Proc Natl Acad Sci U S A on September 30, 2003
Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet (2007) 5.16
Discovering motifs in ranked lists of DNA sequences. PLoS Comput Biol (2007) 4.40
R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Mol Cell (2012) 3.56
Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest (2008) 3.02
Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res (2010) 2.99
Genome-wide prediction of imprinted murine genes. Genome Res (2005) 2.76
Mammalian DNA methyltransferases: a structural perspective. Structure (2008) 2.72
CpG island methylation in human lymphocytes is highly correlated with DNA sequence, repeats, and predicted DNA structure. PLoS Genet (2006) 2.66
Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res (2009) 2.31
Computational prediction of methylation status in human genomic sequences. Proc Natl Acad Sci U S A (2006) 1.83
GC skew at the 5' and 3' ends of human genes links R-loop formation to epigenetic regulation and transcription termination. Genome Res (2013) 1.71
Aging and epigenetic drift: a vicious cycle. J Clin Invest (2014) 1.63
Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia (2010) 1.58
Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics (2010) 1.56
Epigenetic alterations in human prostate cancers. Endocrinology (2009) 1.55
Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res (2010) 1.53
Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab (2009) 1.46
Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet (2010) 1.44
High-fat or ethinyl-oestradiol intake during pregnancy increases mammary cancer risk in several generations of offspring. Nat Commun (2012) 1.35
CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. PLoS Genet (2007) 1.28
Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity. PLoS One (2009) 1.27
TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway. Oncogene (2014) 1.26
DNA methylation patterns in lung carcinomas. Semin Cancer Biol (2009) 1.25
Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer (2010) 1.20
Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Res (2008) 1.19
Discovering high-resolution patterns of differential DNA methylation that correlate with gene expression changes. Nucleic Acids Res (2013) 1.16
A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. Cancer Res (2009) 1.15
CpG islands: algorithms and applications in methylation studies. Biochem Biophys Res Commun (2009) 1.13
Developmental origins of adult disease. Pediatr Clin North Am (2009) 1.13
Genomic insights into cancer-associated aberrant CpG island hypermethylation. Brief Funct Genomics (2013) 1.11
Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology (2009) 1.10
The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas. Clin Cancer Res (2011) 1.09
Early life protein restriction alters dopamine circuitry. Neuroscience (2010) 1.04
SINE retrotransposons cause epigenetic reprogramming of adjacent gene promoters. Mol Cancer Res (2012) 1.01
Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes. Epigenetics (2012) 1.01
Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis. Physiol Genomics (2013) 1.00
Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas. Mol Cell Biol (2013) 1.00
Dissecting DNA hypermethylation in cancer. FEBS Lett (2010) 0.98
Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study. Cancer Res (2011) 0.97
CpGIMethPred: computational model for predicting methylation status of CpG islands in human genome. BMC Med Genomics (2013) 0.97
Poly(ADP-ribosyl)ation acts in the DNA demethylation of mouse primordial germ cells also with DNA damage-independent roles. PLoS One (2012) 0.95
Two tales of antioxidant enzymes on β cells and diabetes. Antioxid Redox Signal (2010) 0.95
Profile analysis and prediction of tissue-specific CpG island methylation classes. BMC Bioinformatics (2009) 0.94
Histone methylation marks play important roles in predicting the methylation status of CpG islands. Biochem Biophys Res Commun (2008) 0.93
Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene Inhibition. Stem Cell Reports (2015) 0.92
Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma. PLoS One (2012) 0.91
Discovery of DNA methylation markers in cervical cancer using relaxation ranking. BMC Med Genomics (2008) 0.91
Putative zinc finger protein binding sites are over-represented in the boundaries of methylation-resistant CpG islands in the human genome. PLoS One (2007) 0.90
Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs. Pharmacogenet Genomics (2011) 0.89
DNA sequence explains seemingly disordered methylation levels in partially methylated domains of Mammalian genomes. PLoS Genet (2014) 0.87
Familial molar tissues due to mutations in the inflammatory gene, NALP7, have normal postzygotic DNA methylation. Hum Genet (2006) 0.86
Linking the epigenome to the genome: correlation of different features to DNA methylation of CpG islands. PLoS One (2012) 0.85
Distinct functional patterns of gene promoter hypomethylation and hypermethylation in cancer genomes. PLoS One (2012) 0.85
A structural split in the human genome. PLoS One (2007) 0.84
Mining methylation for early detection of common cancers. PLoS Med (2006) 0.84
Ovine HSP90AA1 expression rate is affected by several SNPs at the promoter under both basal and heat stress conditions. PLoS One (2013) 0.83
Helicobacter pylori-infection-associated CpG island hypermethylation in the stomach and its possible association with polycomb repressive marks. Virchows Arch (2008) 0.82
A concise review on epigenetic regulation: insight into molecular mechanisms. Int J Mol Sci (2011) 0.81
Flipping the epigenetic switch. Am J Pathol (2004) 0.80
GC skew defines distinct RNA polymerase pause sites in CpG island promoters. Genome Res (2015) 0.79
A novel k-mer mixture logistic regression for methylation susceptibility modeling of CpG dinucleotides in human gene promoters. BMC Bioinformatics (2012) 0.79
Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenetics (2015) 0.78
Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients. Respir Res (2015) 0.77
Predicting DNA Methylation State of CpG Dinucleotide Using Genome Topological Features and Deep Networks. Sci Rep (2016) 0.77
Aberrant CpG islands hypermethylation profiles in malignant gliomas. Brain Tumor Res Treat (2014) 0.75
Haploinsufficiency in multiploid colorectal cancer. J Gastroenterol (2005) 0.75
Computationally expanding infinium HumanMethylation450 BeadChip array data to reveal distinct DNA methylation patterns of rheumatoid arthritis. Bioinformatics (2016) 0.75
Methylation of Werner syndrome protein is associated with the occurrence and development of invasive meningioma via the regulation of Myc and p53 expression. Exp Ther Med (2015) 0.75
Epimutations, inheritance and causes of aberrant DNA methylation in cancer. Hered Cancer Clin Pract (2006) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
DNA methylation patterns and epigenetic memory. Genes Dev (2002) 33.83
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
CpG islands in vertebrate genomes. J Mol Biol (1987) 23.16
Cytosine methylation and the ecology of intragenomic parasites. Trends Genet (1997) 13.66
Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A (2002) 12.33
Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res (1998) 8.95
A gene hypermethylation profile of human cancer. Cancer Res (2001) 8.93
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell (1990) 7.45
Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet (2001) 6.92
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science (2002) 6.05
DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet (2000) 5.09
Computational prediction of eukaryotic protein-coding genes. Nat Rev Genet (2002) 3.97
Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature (2000) 3.78
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res (1999) 3.66
Use of restriction enzymes to detect potential gene sequences in mammalian DNA. Nature (1987) 3.66
Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J (2001) 3.36
Large-scale human promoter mapping using CpG islands. Nat Genet (2000) 3.02
Methylation matters. J Med Genet (2001) 3.00
Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res (2001) 2.60
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50
Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem (1997) 2.27
De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol Cell Biol (1996) 2.26
Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol (2002) 2.24
DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene (2002) 2.23
Restriction landmark genome scanning. Methods (2002) 2.20
Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci U S A (1993) 1.86
Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science (1999) 1.83
Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice. Cancer Res (2002) 1.73
Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res (1998) 1.55
Tandem B1 elements located in a mouse methylation center provide a target for de novo DNA methylation. J Biol Chem (1999) 1.53
Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat Genet (2002) 1.48
Identification of the Meg1/Grb10 imprinted gene on mouse proximal chromosome 11, a candidate for the Silver-Russell syndrome gene. Proc Natl Acad Sci U S A (1998) 1.37
DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. J Biol Chem (2002) 1.26
HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas. Oncogene (2002) 1.23
The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene (2002) 1.22
The establishment and maintenance of DNA methylation patterns in mouse somatic cells. Semin Cancer Biol (1999) 1.17
A distinct sequence (ATAAA)n separates methylated and unmethylated domains at the 5'-end of the GSTP1 CpG island. J Biol Chem (2000) 1.14
Analysis of human peripheral blood T cells and single-cell-derived T cell clones uncovers extensive clonal CpG island methylation heterogeneity throughout the genome. Proc Natl Acad Sci U S A (1999) 0.92
An arrayed human not I-EcoRV boundary library as a tool for RLGS spot analysis. DNA Res (1997) 0.89
Interaction in vitro of type III intermediate filament proteins with triplex DNA. DNA Cell Biol (2002) 0.81
Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res (1998) 8.95
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet (2001) 3.58
Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat Biotechnol (1999) 3.04
Methylation matters. J Med Genet (2001) 3.00
The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis (1998) 2.90
Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study. Aliment Pharmacol Ther (2014) 2.66
Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci U S A (2000) 2.38
Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem (1997) 2.27
Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res (1999) 2.17
Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. Br Med J (1976) 2.16
Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res (1992) 2.10
The Airtraq as a rescue airway device following failed direct laryngoscopy: a case series. Anaesthesia (2007) 2.10
Learning and performance of tracheal intubation by novice personnel: a comparison of the Airtraq and Macintosh laryngoscope. Anaesthesia (2006) 2.08
Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci U S A (1996) 1.99
TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res (2000) 1.98
Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst (1993) 1.94
The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia (2009) 1.93
Response of patients receiving high dose beclomethasone dipropionate. Thorax (1974) 1.72
Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. Thorax (1984) 1.71
Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol (1997) 1.68
Comparison of reagent-impregnated paper strips and conventional methods for identification of Enterobacteriaceae. Am J Clin Pathol (1968) 1.68
Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis (2010) 1.62
Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci U S A (2000) 1.60
Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man. Clin Exp Allergy (1990) 1.49
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci U S A (2001) 1.48
TMS1/ASC: the cancer connection. Apoptosis (2004) 1.46
Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res (1997) 1.43
Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer (2006) 1.41
Effect of potential energy distribution on the melting of clusters. Phys Rev Lett (2001) 1.39
Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res (2011) 1.32
Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells. J Biol Chem (1997) 1.32
A case of spontaneous pneumomediastinum and pneumopericardium in a young adult. Korean J Intern Med (2001) 1.30
Characteristics of prostaglandin induced cough in man. Br J Clin Pharmacol (1985) 1.30
Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Oncogene (2001) 1.30
Evaluation of the Airtraq and Macintosh laryngoscopes in patients at increased risk for difficult tracheal intubation. Anaesthesia (2008) 1.29
Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells. Leukemia (2003) 1.23
Diagnosis and management of alveolar proteinosis: the rôle of electron microscopy. Thorax (1975) 1.23
New 5' regions of the murine and human genes for DNA (cytosine-5)-methyltransferase. J Biol Chem (1996) 1.23
Activation of a caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS1. Cancer Res (2000) 1.17
Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease. Am Rev Respir Dis (1987) 1.17
Effect of short term calorie restriction on pro-inflammatory NF-kB and AP-1 in aged rat kidney. Inflamm Res (2009) 1.14
Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia (2001) 1.14
A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. Genomics (1999) 1.12
Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors. Br J Cancer (2005) 1.11
Evolution of a long-range repeat family in chromosome 1 of the genus Mus. Mamm Genome (1993) 1.08
Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation. Am J Vet Res (1996) 1.08
A case of edematous striae distensae in lupus nephritis. J Dermatol (1999) 1.07
Epidemiological investigation of outbreaks of fowl adenovirus infection in commercial chickens in Korea. Poult Sci (2012) 1.06
Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status. Cancer Res (1997) 1.04
Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene. J Biol Chem (1996) 1.03
Theophylline--an immunomodulatory role in asthma? Am Rev Respir Dis (1993) 1.03
Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys (2000) 1.02
Direct correlation between methylation status and expression of the human O-6-methylguanine DNA methyltransferase gene. Cancer Commun (1991) 1.02
A direct repeat sequence at the Rasgrf1 locus and imprinted expression. Genomics (1999) 1.02
Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene (2007) 1.02
Molecular cloning of polymorphic markers on RLGS gel using the spot target cloning method. Biochem Biophys Res Commun (1993) 1.02
Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility. Oncogene (2001) 1.02
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood (2001) 1.01
Effects of nifedipine on antigen-induced bronchoconstriction. Am Rev Respir Dis (1983) 1.00
Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis. Cell Death Differ (2012) 0.99
Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay. Br J Clin Pharmacol (1987) 0.99
Development and evaluation of an Internet-based distance learning system for public health in Korea. Asia Pac J Public Health (2001) 0.97
Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J Immunol (1997) 0.97
Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis. Cell Death Differ (2006) 0.94
Isolation of polyadenylated RNA from cultured cells and intact tissues. Biotechniques (1993) 0.94
Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene (2012) 0.94
Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor. J Biol Chem (1997) 0.93
Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population. J Med Genet (2000) 0.93
Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovasc Res (2000) 0.93
Absence of imprinting in U2AFBPL, a human homologue of the imprinted mouse gene U2afbp-rs. Biochem Biophys Res Commun (1996) 0.93
Surveillance of avian influenza virus in wild bird fecal samples from South Korea, 2003-2008. J Wildl Dis (2010) 0.93
Structural determinants of spermidine-DNA interactions. Biopolymers (1987) 0.92
Aberrant methylation of genes in low-grade astrocytomas. Brain Tumor Pathol (2000) 0.92
DNA copy number gains in head and neck squamous cell carcinoma. Oncogene (2006) 0.92
Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet (2003) 0.92
Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes Chromosomes Cancer (2001) 0.91
An oocyte-specific methylation imprint center in the mouse U2afbp-rs/U2af1-rs1 gene marks the establishment of allele-specific methylation during preimplantation development. Genomics (1997) 0.91
Human foamy virus Bel1 transactivator contains a bipartite nuclear localization determinant which is sensitive to protein context and triple multimerization domains. J Virol (1995) 0.91
The bronchial response to cold air challenge: evidence for different mechanisms in normal and asthmatic subjects. Thorax (1983) 0.90
Effect of nifedipine on bronchoconstriction induced by inhalation of cold air. Thorax (1983) 0.90
Dual role of TMS1/ASC in death receptor signaling. Oncogene (2006) 0.90
Diminished bronchial reactivity to cold air in diabetic patients with autonomic neuropathy. Br Med J (Clin Res Ed) (1984) 0.90
Potential role of advanced MRI techniques for the peritumoural region in differentiating glioblastoma multiforme and solitary metastatic lesions. Clin Radiol (2013) 0.89
The effect of prednisone treatment on the half-life of intravenous hydrocortisone. Br J Clin Pharmacol (1974) 0.89
An arrayed human not I-EcoRV boundary library as a tool for RLGS spot analysis. DNA Res (1997) 0.89
Tuberculin PPD RT23: has it lost some of its potency? Int J Tuberc Lung Dis (1998) 0.89
Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects. Br J Clin Pharmacol (1992) 0.87
Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma. Oncogene (2012) 0.86
The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjects. Pulm Pharmacol (1990) 0.86
Sputum cysteinyl-leukotriene levels correlate with the severity of pulmonary disease in children with cystic fibrosis. Pediatr Pulmonol (1992) 0.86
Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3. Pharmacogenomics J (2012) 0.86
An optimization model for constrained discriminant analysis and numerical experiments with iris, thyroid, and heart disease datasets. Proc AMIA Annu Fall Symp (1996) 0.85
Comparative mapping of the imprinted U2afbpL gene on mouse chromosome 11 and human chromosome 5. Cytogenet Cell Genet (1995) 0.85
O6-methylguanine-DNA methyltransferase in tumors and cells of the oligodendrocyte lineage. Can J Neurol Sci (1995) 0.85